A UNIVERSITY has signed a licensing agreement with a new Irish biotech company to develop ‘tailor-made’ drugs that could give new hope to cancer patients.

EIRX Therapeutics, the Cork-based drug discovery firm, has applied to put its Irish unit into liquidation.

DR IAN HAYES, the chief executive and co-founder of EiRx Therapeutics, has left the Cork-based pharmaceutical company.